Log in
Enquire now
‌

US Patent 10137120 Aza-aryl 1H-pyrazol-1-yl benzene sulfonamides

Patent 10137120 was granted and assigned to ChemoCentryx on November, 2018 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
0
Current Assignee
ChemoCentryx
ChemoCentryx
0
Date Filed
November 14, 2014
0
Date of Patent
November 27, 2018
0
Patent Applicant
ChemoCentryx
ChemoCentryx
0
Patent Application Number
14541637
0
Patent Citations Received
‌
US Patent 11883391 Compositions and methods for treating inflammatory bowel disease using CCR9 inhibitor and anti-IL-23 blocking antibodies
0
Patent Inventor Names
Jay P. Powers
0
Rebecca M. Lui
0
Xi Chen
0
Yibin Zeng
0
Antoni Krasinski
0
Jeffrey P. McMahon
0
Junfa Fan
0
Lianfa Li
0
Penglie Zhang
0
Pingchen Fan
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
10137120
0
Patent Primary Examiner
‌
Jeffrey S Lundgren
0

Find more entities like US Patent 10137120 Aza-aryl 1H-pyrazol-1-yl benzene sulfonamides

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.